
TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
VL  - 37
IS  - s1
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2007.01791.x
DO  - doi:10.1111/j.1365-2362.2007.01791.x
SP  - 15
EP  - 83
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Session I (Abstracts 259 – 729)
JO  - Hepatology
JA  - Hepatology
VL  - 64
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.28797
DO  - doi:10.1002/hep.28797
SP  - 136
EP  - 361
PY  - 2016
ER  - 

C7  - pp. 1-482
TI  - English-French-German
SN  - 9783826334054
UR  - https://doi.org/10.1002/9780470760338.ch1
DO  - doi:10.1002/9780470760338.ch1
SP  - 1-482
PY  - 2016
AB  - Summary This chapter contains sections titled: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ER  - 

C7  - pp. 501-535
TI  - Liver and Pancreas
SN  - 9780781796439
UR  - https://doi.org/10.1002/9780813818825.ch11
DO  - doi:10.1002/9780813818825.ch11
SP  - 501-535
KW  - Background Information of Clinical Importance
KW  - Diagnosis of Hepatic Disease by Presenting Sign
KW  - Specific Diseases of the Liver
KW  - Stilesia and Thysonasoma Tapeworm Infections
KW  - Echinococcus or Hydatid Disease
KW  - Nutritional and Metabolic Diseases
KW  - General Features of Toxic Hepatitis
KW  - Chemical and Drug-Related Causes of Toxic Hepatitis
KW  - Plants Causing Toxic Hepatitis
KW  - Fungal and Mycotoxic Causes of Toxic Hepatitis
PY  - 2016
AB  - Summary This chapter contains sections titled: Background Information of Clinical Importance Diagnosis of Hepatic Disease by Presenting Sign Specific Diseases of the Liver Viral Diseases Bacterial Diseases Parasitic Diseases Nutritional and Metabolic Diseases Toxicologic Diseases Neoplastic Diseases Diabetes Mellitus References
ER  - 

TY  - JOUR
TI  - Abstracts of the 76th Annual Meeting of the Japanese Cancer Association; 2017 Sept 28-30; Yokohama, Japan
JO  - Cancer Science
JA  - Cancer Sci
VL  - 109
IS  - S1
SN  - 9780781796439
UR  - https://doi.org/10.1111/cas.13499
DO  - doi:10.1111/cas.13499
SP  - 1
EP  - 1325
PY  - 2018
ER  - 

TY  - JOUR
TI  - Citations from World Literature
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 2
IS  - 3
SN  - 9780781796439
UR  - https://doi.org/10.1177/014860717800200310
DO  - doi:10.1177/014860717800200310
SP  - 247
EP  - 448
PY  - 1978
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 18
IS  - S1
SN  - 9780781796439
UR  - https://doi.org/10.1002/ejhf.539
DO  - doi:10.1002/ejhf.539
SP  - 8
EP  - 521
PY  - 2016
ER  - 

TY  - JOUR
TI  - Index of biochemical reviews
JO  - FEBS Letters
VL  - 256
IS  - S1
SN  - 9780781796439
UR  - https://doi.org/10.1016/0014-5793(89)81702-8
DO  - doi:10.1016/0014-5793(89)81702-8
SP  - 1
EP  - 230
PY  - 1989
ER  - 

TY  - JOUR
TI  - Contents
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 30
IS  - S1
SN  - 9780781796439
UR  - https://doi.org/10.1007/s10545-007-9987-1
DO  - doi:10.1007/s10545-007-9987-1
SP  - 1
EP  - 178
PY  - 2007
ER  - 

TY  - JOUR
TI  - Award Winners and Abstracts of the 32nd Annual Symposium of The Protein Society; Boston, MA, July 9–12, 2018
JO  - Protein Science
JA  - Protein Science
VL  - 27
IS  - S1
SN  - 9780781796439
UR  - https://doi.org/10.1002/pro.3513
DO  - doi:10.1002/pro.3513
SP  - 11
EP  - 245
PY  - 2018
ER  - 

AU  - Fricker, Simon P.
C7  - pp. 1-20
TI  - Nitrogen Monoxide (Nitric Oxide): Bioinorganic Chemistry
UR  - https://doi.org/10.1002/9781119951438.eibc2724
DO  - doi:10.1002/9781119951438.eibc2724
SP  - 1-20
KW  - nitrogen monoxide
KW  - nitric oxide
KW  - nitric oxide synthase
KW  - peroxynitrite
KW  - nitrosothiol
KW  - soluble guanylate cyclase
KW  - phosphodiesterase 5
KW  - hemoglobin
PY  - 2018
AB  - Abstract The discovery of nitrogen monoxide (nitric oxide, NO) as the vasodilator molecule endothelium-derived relaxing factor revealed a major physiological role for this simple diatomic molecule. We now know that NO regulates cardiovascular function, is a neurotransmitter, and is a component of the innate immune response to infection and cancer. The physiological effects of NO are mediated by its varied chemistry which includes redox chemistry and interaction with transition metals. NO can interact with iron-heme-containing proteins including hemoglobin and cytochrome c oxidase, and nonheme iron proteins such as aconitase and bacterial transcription regulatory proteins. NO reacts with superoxide to form the highly reactive peroxynitrite which decomposes to give the hydroxyl radical. Nitrosothiols, thiol adducts of NO, act to control NO release, and to shuttle NO between proteins and transport NO across cell membranes. NO is produced by one of three nitric oxide synthase (NOS) enzymes, endothelial NOS, neuronal NOS, and inducible NOS. Signaling functions are mediated via interaction with the heme-containing protein soluble guanylate cyclase (GC), which produces the cell signaling molecule cyclic guanosine monophosphate (cGMP). This, in turn, is hydrolyzed by phosphodiesterase 5 (PDE5), which turns off NO signaling. Perturbation in NO function contributes to the pathophysiology of many disease states. Endothelial dysfunction and subsequent reduced NO production contribute to hypertension and atherosclerosis. Excess NO is a mediator of inflammatory disease, and neurodegenerative disease, due in part to the production of peroxynitrite. The cardiovascular collapse observed in septic shock is caused by the vasodilator action of NO. Targeting the NO pathway theoretically provides many opportunities for therapeutic intervention. The NO donor drugs glyceryl trinitrate, isosorbide mononitrate, isosorbide dinitrate, and amyl nitrate are used to treat acute angina; and inhaled NO is used to treat persistent pulmonary hypertension in new born infants. Conversely, NOS inhibitors and NO scavengers have been explored to counteract NO as a mediator of disease. Though promising results have been obtained in animal models of disease these latter approaches have had little clinical success. However, targeting downstream of NO has been more successful with new clinically approved classes of drugs such as the inhibitors of PDE5 sildenafil, tadalafil, and vardenafil; and the stimulator of the NO receptor soluble GC, riociguat. It has become apparent that the biological actions, and biological chemistry, of NO are very complex. New opportunities for drug discovery could result from an improved understanding of the biology of NO.
ER  - 

TY  - JOUR
TI  - THIRD MEETING OF THE INTERNATIONAL SOCIETY FOR ARTIFICIAL ORGANS July 8–10, 1981
JO  - Artificial Organs
VL  - 5
IS  - 1
UR  - https://doi.org/10.1111/j.1525-1594.1981.tb01639.x
DO  - doi:10.1111/j.1525-1594.1981.tb01639.x
SP  - 1
EP  - 94
PY  - 1981
ER  - 

TY  - JOUR
TI  - Symposium Session Summaries
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 48
IS  - S36
UR  - https://doi.org/10.1002/ppul.22896
DO  - doi:10.1002/ppul.22896
SP  - 103
EP  - 206
PY  - 2013
ER  - 

TY  - JOUR
TI  - ACTS Abstracts
JO  - Clinical and Translational Science
JA  - Clinical And Translational Science
VL  - 8
IS  - 3
UR  - https://doi.org/10.1111/cts.12290
DO  - doi:10.1111/cts.12290
SP  - 178
EP  - 258
PY  - 2015
ER  - 

TY  - JOUR
TI  - Non- Moderated Posters
JO  - BJU International
VL  - 94
IS  - s2
UR  - https://doi.org/10.1111/j.1465-5101.2004.05080.x
DO  - doi:10.1111/j.1465-5101.2004.05080.x
SP  - 163
EP  - 309
PY  - 2004
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Tropical Medicine & International Health
VL  - 16
IS  - s1
UR  - https://doi.org/10.1111/j.1365-3156.2011.02861.x
DO  - doi:10.1111/j.1365-3156.2011.02861.x
SP  - 97
EP  - 384
PY  - 2011
ER  - 

TY  - JOUR
TI  - OLIV SIG 2 – Transplantation
JO  - Respirology
VL  - 14
IS  - s1
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_11.x
DO  - doi:10.1111/j.1440-1843.2009.01503_11.x
SP  - A71
EP  - A75
PY  - 2009
ER  - 

TY  - JOUR
TI  - Sleep & Physiology SIG
JO  - Respirology
VL  - 14
IS  - s1
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_16.x
DO  - doi:10.1111/j.1440-1843.2009.01503_16.x
SP  - A85
EP  - A89
PY  - 2009
ER  - 

TY  - JOUR
TI  - Posters
JO  - Glia
JA  - Glia
VL  - 57
IS  - S13
UR  - https://doi.org/10.1002/glia.20915
DO  - doi:10.1002/glia.20915
SP  - S26
EP  - S171
PY  - 2009
ER  - 

TY  - JOUR
TI  - Respiratory Nurses SIG
JO  - Respirology
VL  - 14
IS  - s1
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_15.x
DO  - doi:10.1111/j.1440-1843.2009.01503_15.x
SP  - A84
EP  - A85
PY  - 2009
ER  - 
